CLEC19A and central nervous system cancer: The results corroborated that CLEC19A expression is statistically significantly reduced in aggressive glioma cell lines including A172, U87, and C6 relative to 1321N1 low-grade astrocytoma cells (p < 0.05) (Fig. 2C).